Mireille Thomas

Title: Mireille Thomas: Innovator in Immunology

Introduction

Mireille Thomas is a notable inventor based in Strasbourg, France. She has made significant contributions to the field of immunology, particularly in the development of methods for identifying T cell responses. Her work has implications for therapeutic applications in cancer treatment.

Latest Patents

Mireille Thomas holds a patent titled "Method of identifying a MHC class I restricted T cell response." This patent describes peptides and polypeptides derived from the MUC-1 polypeptide that can activate Cytotoxic T Lymphocyte (CTL) responses. The patent also includes analogues of these peptides and polypeptides, as well as nucleotide sequences encoding them. Furthermore, it outlines therapeutic uses and provides indications for selecting appropriate minimal antigenic MUC-1 polypeptides based on the HLA-type of the patient being treated or tested. She has 1 patent to her name.

Career Highlights

Throughout her career, Mireille has worked with prominent organizations, including Imperial Cancer Research Technology Ltd. and Transgene S.A. Her experience in these companies has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Mireille has collaborated with notable colleagues such as Lukas Carl Heukamp and Cornelis Johanna Maria Melief. These partnerships have enriched her research and expanded the impact of her innovations.

Conclusion

Mireille Thomas is a pioneering inventor whose work in immunology has the potential to advance cancer therapies significantly. Her contributions to the field are invaluable, and her patent reflects her commitment to improving patient outcomes.